1139TiP IDE196 (darovasertib) in combination with crizotinib versus investigator’s choice of treatment as first-line therapy in HLA-A2 negative metastatic uveal melanoma
| Autor: | Butler, M.O., Weight, R., Haq, R., Javed, A., Chandana, S., Chmielowski, B., Dummer, R., Carlino, M.S., Mckean, M., Moser, J., Chandrasekaran, S., Khan, S., Kim, K.B., Lutzky, J., Shackleton, M., Atkinson, V.G., Beaupre, D., Cole, G.W., Jr, Patel, H., Orloff, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S747-S747 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|